Skip to Content

AML Insights: What’s New in the Field

Discover the key developments in the treatment of acute myeloid leukemia, including the role of menin inhibitors, MRD-guided therapy, and new combination regimens involving chidamide and FLT3-targeted agents. Several studies also address challenges in high-risk patient groups, such as those with TP53 mutations.
Don’t miss these exciting developments!

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top